Lifevantage (LFVN) Research & Development (2010 - 2014)

Lifevantage (LFVN) has reported Research & Development for 5 consecutive years, with $32.5 million the latest figure, recorded in Q1 2014.

• For the quarter ending Q1 2014, Research & Development rose 8.84% year-over-year to $32.5 million; the trailing twelve-month figure through Mar 2014 stood at $125.9 million (up 11.16% YoY), and the FY2013 full-year result was $122.4 million, up 78.94% from the prior year.
• Research & Development grew to $32.5 million in Q1 2014 per LFVN's latest filing, from $29.8 million in the prior quarter.
• Across five years, Research & Development topped out at $33.4 million in Q2 2013 and bottomed at $3.4 million in Q3 2010.
• Historically, Research & Development has averaged $20.3 million across 5 years, with a median of $24.3 million in 2012.
• The sharpest annual moves came in 2012 and 2013: Research & Development jumped 267.75% in 2012, then rose 0.65% in 2013.
• Over 5 years, Research & Development stood at $4.0 million in 2010, then soared by 245.17% to $13.9 million in 2011, then jumped by 113.24% to $29.6 million in 2012, then climbed by 0.65% to $29.8 million in 2013, then gained by 9.06% to $32.5 million in 2014.
• According to Business Quant data, Research & Development over the past three periods registered $32.5 million, $29.8 million, and $30.2 million for Q1 2014, Q4 2013, and Q3 2013 respectively.